Sonova Aims for 7.6 Billion Dollars in Revenue by 2031

The hearing aid maker expects annual sales growth of 5 to 10 percent. It aims to reach 6 billion Swiss francs in revenue by the 2030/31 financial year end.

Xurve View
Insights:

The global hearing aid industry leader, SONOVA HOLDING AG-REG, has outlined a new strategic roadmap aimed at securing robust financial performance through the end of the decade. Headquartered in Switzerland, the company is adapting its operations to counter a slowing market and rising competitive threats under the direction of its recently appointed management team. In its latest medium-term guidance, the manufacturer projected that annual sales will grow at a rate of 5% to 10% in local currencies. These projections are part of a broader ambition to reach 6 billion Swiss francs, or roughly $7.6 billion, in total revenue by the 2030/31 financial year. Beyond top-line growth, Sonova is focusing on enhancing its profitability. The company expects its core operating profit to expand by 7% to 12% annually during this period. This outlook reflects the firm's efforts to streamline operations and leverage its scale as it faces a more challenging macroeconomic environment for medical devices.

IUX24

IUX24 AI-powered financial news and market intelligence. Think and act like smart money.

IFZA Properties, Dubai Silicon Oasis, DSO-IFZA, Dubai, United Arab Emirates

Copyright IUX24 MEDIA - FZCO. All rights reserved.

Powered by AI • Made with precision

IUX24 is an information and analytics platform providing news, market data, analytical tools, and AI-powered features for informational and educational purposes. The Services and information provided do not constitute investment advice, trading signals, or brokerage services. Investing involves risk, and Users should carefully evaluate information before making investment decisions.